A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Meghan Thompson, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Memorial Sloan Kettering Basking Ridge (all Protocol Activities)
Basking Ridge, New Jersey, United States
- Hackensack Meridian Health (data Collection Only)
Hackensack, New Jersey, United States
- Memorial Sloan Kettering Monmouth (all Protocol Activities)
Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (all Protocol Activities)
Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack (all Protocol Activities)
Commack, New York, United States
- Memorial Sloan Kettering Westchester (all Protocol Activities)
Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center (all Protocol Activities)
New York, New York, United States
- Memorial Sloan Kettering Nassau (all Protocol Activities)
Uniondale, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 May 2021
- Primary completion
- 28 Feb 2027
- Completion
- 28 Feb 2027
- Last update posted
- 4 Jun 2026
- Registered enrollment
- 55
- Registry id
- NCT04722172
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.